Why the study?
Insulin resistance is linked to cardiovascular disease in nondiabetic patients, but the association of the TyG index with obstructive CAD and potential sex differences required investigation.
Does a higher triglyceride-glucose index associate with an increased risk of obstructive coronary artery disease in patients with stable angina pectoris?
Does a higher triglyceride-glucose index associate with an increased risk of obstructive coronary artery disease in patients with stable angina pectoris?
A higher triglyceride-glucose index is independently associated with an increased risk of obstructive coronary artery disease in non-diabetic women, suggesting its potential utility as a surrogate marker for insulin resistance and cardiovascular risk in this population.
Answers are grounded in this paper and cite their sources.
TyG index may flag obstructive CAD risk in stable angina; leaves open incremental value and sex-specific thresholds for prospective validation.
Background Insulin resistance is associated with cardiovascular disease in nondiabetic patients. The triglyceride-glucose (TyG) index, incorporating serum glucose and insulin concentrations, is a surrogate insulin resistance marker. We investigated its association with obstructive coronary artery disease (CAD) and sex differences therein. Methods Patients with stable angina pectoris requiring invasive coronary angiography between January 2010 and December 2018 were enrolled. They were divided into two groups according to TyG indices. Two interventional cardiologists diagnosed obstructive CAD by angiography review. Demographic characteristics and clinical outcomes were compared between groups. Results Relative to lower indices, patients with higher (≥ 8.60) TyG indices had higher BMIs and more prevalent hypertension, diabetes, and elevated lipid profiles [total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein, triglycerides, fasting plasma glucose]. Higher TyG indices increased women’s obstructive CAD risk after adjustment for age; smoking; BMI; hypertension; congestive heart failure; stroke; diabetes; LDL; estimated glomerular filtration rate; and statin, antiplatelet agent, and angiotensin-converting enzyme inhibitor/angiotensin receptor blocker use (adjusted odds ratio 2.15, 95% confidence interval 1.08–4.26, p = 0.02). No sex difference was found for diabetic patients. Conclusion Higher TyG indices significantly increased the obstructive CAD risk, overall and for non-diabetic women. Larger-scale studies are needed to confirm our findings.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2022) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: